chr10-103602141-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001394015.1(SH3PXD2A):c.3077C>T(p.Ala1026Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000342 in 1,577,994 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A1026T) has been classified as Uncertain significance.
Frequency
Consequence
NM_001394015.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SH3PXD2A | NM_001394015.1 | c.3077C>T | p.Ala1026Val | missense_variant | 15/15 | ENST00000369774.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SH3PXD2A | ENST00000369774.9 | c.3077C>T | p.Ala1026Val | missense_variant | 15/15 | 5 | NM_001394015.1 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152210Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000405 AC: 9AN: 222154Hom.: 0 AF XY: 0.0000337 AC XY: 4AN XY: 118636
GnomAD4 exome AF: 0.0000365 AC: 52AN: 1425784Hom.: 0 Cov.: 63 AF XY: 0.0000426 AC XY: 30AN XY: 704532
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152210Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 10, 2022 | The c.2993C>T (p.A998V) alteration is located in exon 14 (coding exon 14) of the SH3PXD2A gene. This alteration results from a C to T substitution at nucleotide position 2993, causing the alanine (A) at amino acid position 998 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at